Undisclosed Biologics Pipeline

About Fable Therapeutics

Fable Therapeutics is a private, preclinical-stage biotech leveraging a proprietary AI/ML platform for the design of novel biologics targeting metabolic diseases, with a primary focus on obesity and its complications. The company's core technology harmonizes vast biological datasets with sophisticated computation to engineer proteins with optimized properties, aiming to overcome limitations of current therapies. While still early-stage and pre-revenue, Fable is positioning itself in the high-growth metabolic disease market by attempting to create next-generation therapeutics with potentially superior efficacy and specificity. Its success hinges on validating its platform through preclinical and clinical development of its internal pipeline.

Therapeutic Areas